McL-1 Is an Important Determinant of the Apoptotic Response to the BH3-mimetic Molecule HA14-1 in Cisplatin-Resistant Ovarian Carcinoma Cells
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0493
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2009
Authors
Publisher
American Association for Cancer Research (AACR)